Health
New York: Novavax, Inc, a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, on Tuesday announced that it has been selected to participate in Operation Warp Speed (OWS), a U.S. government program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 in 2021. more